Full-Time

Quality Control Analyst 3

Curia

Curia

1,001-5,000 employees

End-to-end drug development and manufacturing

Compensation Overview

$84k - $104k/yr

+ 401(k) matching contributions

Rensselaer, NY, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
ISO 9001
Data Analysis

Get referred to Curia

See people who can refer or advise you

Requirements
  • A Bachelor's degree in Chemistry or a related field is required.
  • A minimum of 5-7 years of pharmaceutical experience or an equivalent combination of education and experience is required.
  • The candidate must be able to meet deadlines and work under pressure with limited supervision.
  • The candidate must have strong time management and organizational skills and be able to multitask and manage multiple projects independently.
  • The candidate must be able to read, analyze, and interpret business periodicals, professional journals, technical procedures, and governmental regulations.
  • The candidate must be able to write reports, business correspondence, and procedure manuals.
  • The candidate must be able to apply advanced mathematical concepts, including exponents, logarithms, quadratic equations, and permutations.
  • The candidate must be able to apply mathematical operations to frequency distribution, test reliability and validity, analysis of variance, correlation techniques, sampling theory, and factor analysis.
  • The candidate must be able to define problems, collect data, establish facts, and draw valid conclusions.
  • The candidate must be able to interpret technical instructions in mathematical or diagram form and work with abstract and concrete variables.
  • The candidate must be proficient in Microsoft Office Suite and instrument manufacturer-based systems.
  • The candidate must have knowledge of FDA good manufacturing practices, including 21 CFR Parts 211, 820, and/or 600.
  • The candidate must be able to perform the physical requirements of the role, including standing, walking, sitting, handling materials, and lifting up to 25 pounds.
  • The candidate must be able to work in an environment involving fumes, airborne particles, toxic or caustic chemicals, and other listed workplace hazards.
Responsibilities
  • Perform complex testing and data evaluation, including thermogravimetric analysis.
  • Perform complex liquid chromatography, gas chromatography, ultra-performance liquid chromatography, and other testing, and troubleshoot issues as needed.
  • Participate in or assist with test method validations.
  • Evaluate data for trends.
  • Support supervisors in out-of-specification investigations and complete corrective and preventive action requirements.
  • Interact with outside departments by attending meetings and providing updates.
  • Coordinate testing performed at outside testing laboratories and testing of raw materials.
  • Maintain detailed and accurate records of activities and results.
  • Execute, author, and review standard operating procedures, reports, protocols, investigations, change controls, and data summaries.
  • Use basic risk assessment and root cause analysis tools.
  • Train on and understand methods, equipment, and standard operating procedures.
  • Provide training to others as needed and attend internal and external training on related subjects, including cross-training on new techniques and procedures.
  • Support equipment upkeep and laboratory method troubleshooting.
  • Provide technical assistance during the shift for test method troubleshooting.
  • Prepare and order supplies as necessary.
  • Enter data into relevant data management systems and perform data tracking and trending as requested.
  • Compile data and provide data summaries to management.
  • Apply regulatory and compliance guidelines for the pharmaceutical industry.
  • Interact with other departments within the company regarding testing needs and scheduling.
  • Lead departmental projects as applicable and participate in or lead cross-functional teams, including continuous improvement projects and new customer teams.
  • Lead the stability program as applicable, including management of test points, reporting of data, and investigations of out-of-specification or aberrant stability results.
Desired Qualifications
  • Experience working in a current good manufacturing practice or good laboratory practice pharmaceutical industry environment.
  • Knowledge of ISO 9001 and ISO 13485.

Curia is a contract development and manufacturing organization (CDMO) that partners with pharmaceutical and biotech companies to move medical breakthroughs from concept to market. It provides end-to-end services across the drug development lifecycle, including early research, method development and validation, preformulation, material science, solid-state chemistry, and package device testing. Revenue comes from service contracts for specialized capabilities and expertise, with clients ranging from small startups to large pharma. Curia also collaborates with industry leaders to advance continuous flow development and manufacturing programs. The company differentiates itself through flexible and scalable solutions, deep scientific expertise, and state-of-the-art technology that help clients accelerate development timelines while navigating discovery to commercialization. Its goal is to enable efficient, reliable progression of drug candidates from conception through to market approval.

Company Size

1,001-5,000

Company Stage

Debt Financing

Total Funding

$132M

Headquarters

Albany, New York

Founded

1991

Get referred to Curia

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Curia expanded Glasgow sterile drug product capacity in March 2026.
  • Curia completed a $4 million sterile API upgrade in Valladolid in October 2025.
  • Curia won a 2025 CDMO Leadership Award in Global Biologics.

What critics are saying

  • Curia is closing Burlington in 2026 and cutting 81 jobs.
  • Curia is working on an out-of-court restructuring with private credit lenders.
  • Asset sales like Pace’s New Jersey lab purchase signal continued portfolio shrinkage.

What makes Curia unique

  • Curia spans discovery through commercial manufacturing across small molecules and biologics.
  • Curia manufactures mRNA and self-replicating RNA, including Replicate Bioscience’s RBI-4000.
  • Curia runs 20+ global sites with sterile fill-finish and cell-line development.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid Vacation

401(k) Retirement Plan

401(k) Company Match

Tuition Reimbursement

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Carlyle
Jan 30th, 2026
AMRI Announces Completion of Acquisition by The Carlyle Group and GTCR | Carlyle

ALBANY, N.Y. – Albany Molecular Research, Inc. (NASDAQ:AMRI), a global contract research, development and manufacturing organization working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, today announced the completion of its previously announced acquisition by affiliates of The Carlyle Group (“Carlyle”) and affiliates of GTCR LLC (“GTCR”). President and Chief Executive Officer William S. Marth will continue to lead AMRI.

BERNAMA
May 10th, 2024
BIOLOGICS SYMPOSIUM: CURIA, CARTERRA PARTNER TO ADVANCE BIOTECH RESEARCH IN PACIFIC NORTHWEST

KUALA LUMPUR, May 10 (Bernama) - Curia, a contract research, development and manufacturing organisation (CDMO) has announced a partnership with Carterra Inc in hosting a high-throughput biologics symposium slated for May 31, in Seattle, Washington.

PharmiWeb
Mar 14th, 2024
Pace® Life Sciences Acquires New Jersey Laboratory From Curia

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Pakistan Press International
Feb 23rd, 2024
Curia Appoints Steve Lavezoli as Vice President, Biologics

ALBANY, N.Y., Feb. 23, 2024 (GLOBE NEWSWIRE) - Curia, a leading contract research, development and manufacturing organization, today announced it has appointed Steve Lavezoli as vice president of biologics effective Feb. 26.

Cameroon Online News
Feb 5th, 2024
Curia Receives 2024 CDMO Leadership Award

Curia was awarded based on the feedback of respondents in the Small Pharma category.